Top Stories

Sustainability-focused private equity firms share their thoughts on the bipartisan infrastructure bill that touches upon climate change.

The anticipated sale process comes fresh on the heels of GHO Capital’s recent $700m-plus bet for another life sciences strategy consulting business, ClearView Healthcare Partners.

Coatue Management, ICONIQ Capital and Adams Street join hands to invest in a company looking to revolutionize how patients access and are enrolled in clinical trials.

Accounting for Arcadia proceeds and prior Fund 4 exits – Organogensis and MPI Research – the vehicle will have returned approximately $1.4bn to investors, according to an LP letter.

After seven years, the firm looks to exit its investment in the provider of passive containers that ship temperature-sensitive commercial and clinical trial products.

As the general population continues to integrate technology more and more into their daily lives, there is a certain level of digital aptitude that they expect from their towns and cities, according to TPG's Millikin.

Clinching its first US-based investment, Europe's PAI wants to follow the Ecotone playbook with Nestle's Tropicana and Naked Juice brands.

The global strategy consulting firm for the life sciences industry commands a more than $700m valuation, concluding a Houlihan Lokey-conducted sale process.

Macquarie, which is providing financial advice on the sale, recently accepted first-round bids for the EdTech company, sources said.

Regal HCP sees big gains across its first two vehicles as it sells down positions in two healthcare businesses, returning more than 1.5x its sophomore fund via Thriveworks.